Cargando…

P1001: MODULATION OF MUTANT CALRETICULIN-DRIVEN ONCOGENESIS IN MYELOPROLIFERATIVE NEOPLASMS BY CLASSICAL HLA GENES

Detalles Bibliográficos
Autores principales:	Shivarov, Velizar, Tsvetkova, Gergana, Micheva, Ilina, Lesichkova, Spaska, Petrova, Jasmina, Ivanova, Anela, Madjarova, Galia, Hadjiev, Evgueniy, Ivanova, Milena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431460/ http://dx.doi.org/10.1097/01.HS9.0000970908.43993.99

Ejemplares similares

Novel Multiplex Bead-Based Assay for Detection of IDH1 and IDH2 Mutations in Myeloid Malignancies
por: Shivarov, Velizar, et al.
Publicado: (2013)

P1064: CIRCULATING CYTOKINE LEVELS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS – PROFILE AND CLINICAL CORRELATIONS – A SINGLE CENTER STUDY
por: Tsvetkova, G., et al.
Publicado: (2022)

Calreticulin Mutations in Myeloproliferative Neoplasms
por: Lavi, Noa
Publicado: (2014)

Mutant Calreticulin in the Myeloproliferative Neoplasms
por: Prins, Daniel, et al.
Publicado: (2020)

Calreticulin Exon 9 Mutations in Myeloproliferative Neoplasms
por: Ha, Jung-Sook, et al.
Publicado: (2015)

Mutated calreticulin retains structurally disordered C terminus that cannot bind Ca(2+): some mechanistic and therapeutic implications
por: Shivarov, V, et al.
Publicado: (2014)

Rapid Detection of DNMT3A R882 Mutations in Hematologic Malignancies Using a Novel Bead-Based Suspension Assay with BNA(NC) Probes
por: Shivarov, Velizar, et al.
Publicado: (2014)

Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
por: Pecquet, Christian, et al.
Publicado: (2023)

Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods
por: Park, Ji-Hye, et al.
Publicado: (2015)

The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
por: Wang, Jingyi, et al.
Publicado: (2016)

A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
por: Rosso, Valentina, et al.
Publicado: (2016)

Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin
por: Edahiro, Yoko, et al.
Publicado: (2020)

Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms
por: Machado-Neto, João Agostinho, et al.
Publicado: (2015)

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
por: Vannucchi, A M, et al.
Publicado: (2014)

Presbyopia correction with a new Extended Depth of Focus Intraocular Lens
por: Hristova, Rozaliya, et al.
Publicado: (2022)

The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation
por: Mansier, Olivier, et al.
Publicado: (2019)

Production and Characterization of Peptide Antibodies to the C-Terminal of Frameshifted Calreticulin Associated with Myeloproliferative Diseases
por: Mughal, Farah Perveen, et al.
Publicado: (2022)

Low neutrophil alkaline phosphatase score is a new aspect of calreticulin-mutated myeloproliferative neoplasms
por: Kondo, Toshinori, et al.
Publicado: (2016)

Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2(V617F) mutation
por: Guy, Alexandre, et al.
Publicado: (2023)

1001 noches.
Publicado: (1945)

MONO 1001
por: Pacquet, J Y, et al.
Publicado: (2002)

Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
por: Naumova, Elissaveta, et al.
Publicado: (2022)

Mild to moderate clinical course of COVID-19 infection in patients with common variable immune deficiency
por: Lesichkova, Spaska, et al.
Publicado: (2023)

Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?
por: Ramírez-Toloza, Galia, et al.
Publicado: (2016)

Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN
por: Benlabiod, Camélia, et al.
Publicado: (2020)

Prognostic Utility of CD47 in Cancer of the Uterine Cervix and the Sensitivity of Immunohistochemical Scores
por: Yordanov, Angel, et al.
Publicado: (2022)

Seasonal Pattern of Cerebrovascular Fatalities in Cancer Patients
por: Shivarov, Velizar, et al.
Publicado: (2023)

Seasonality of Deaths Due to Heart Diseases among Cancer Patients
por: Shivarov, Velizar, et al.
Publicado: (2022)

1001 words for success
por: Brenner, Erin
Publicado: (2012)

1001 trucos publicitarios /
por: Dupont, Luc, 1964-
Publicado: (2004)

1001 MCSE tips /
por: Stigler, Shane
Publicado: (1998)

Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases
por: Tsvetkova, Dobrina, et al.
Publicado: (2022)

Comparisons of +3179G/A insulin-like growth factor 1 receptor gene distribution between two inflammatory arthritides and healthy adults
por: IVANOVA, Mariana, et al.
Publicado: (2021)

Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010)

On Two Cases with Autosomal Dominant Hyper IgE Syndrome: Importance of Immunological Parameters for Clinical Course and Follow-Up
por: Kandilarova, Snezhina Mihailova, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms
por: Secardin, Lise, et al.
Publicado: (2021)

The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence
por: Ramírez-Toloza, Galia, et al.
Publicado: (2020)

Calreticulin and the Heart
por: Groenendyk, Jody, et al.
Publicado: (2022)

Biclonal myeloma in renal failure
por: NIKOLOVA-VLAHOVA, MILENA K., et al.
Publicado: (2020)

1001 formas de motivar /
por: Nelson, Bob, 1956-
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_0321t8vslc56vm0ee3kibj7ijr